Evidence map›Paper›PMID 24879584›Full record

ReviewMolecules (Basel, Switzerland)2014

Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy.

Francesco Cellini, Alessio G Morganti, Domenico Genovesi, Nicola Silvestris, Vincenzo Valentini

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Francesco CelliniRadiation Oncology Department, Policlinico Universitario Campus Bio-Medico; Via Álvaro del Portillo 200, 00144 Rome, Italy. f.cellini@unicampus.it.
Alessio G MorgantiRadiotherapy Department, Università Cattolica del Sacro Cuore; Fondazione di Ricerca e Cura "Giovanni Paolo II", Largo Agostino Gemelli 1, 86100 Campobasso, Italy. amorganti@rm.unicatt.it.
Domenico GenovesiRadiation Oncology Department, Università "G. D'Annunzio"; Via dei Vestini 31, 66100 Chieti, Italy. d.genovesi@unich.it.
Nicola SilvestrisMedical Oncology Unit - Cancer Institute "Giovanni Paolo II"; Viale Orazio Flacco, 65, 70124 Bari, Italy. n.silvestris@oncologico.bari.it.
Vincenzo ValentiniRadiation Oncology Department, Università Cattolica del Sacro Cuore; L.go Francesco Vito 1, 00168 Roma, Italy. vvalentini@rm.unicatt.it.
Università Cattolica del Sacro Cuore · ITCampus Bio Medico University Hospital · ITIstituto Tumori Bari · ITUniversity of Chieti-Pescara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNA) are small, non-coding, RNAs with gene expression regulator roles. As an important class of regulators of many cellular pathways, miRNAs are involved in many signaling pathways and DNA damage repair processes, affecting cellular radiosensitivity. Their role has led to interest in oncological implications to improve treatment results. MiRNAs represent a great opportunity to enhance the efficacy of radiotherapy treatments-they can be used to profile the radioresistance of tumors before radiotherapy, monitor their response throughout the treatment, thus helping to select intensification strategies, and also to define the final response to therapy along with risks of recurrence or metastatization. Even though many interesting studies support such potential, nowadays most studies on patient data are limited to experiments profiling tumor aggressiveness and response to radiotherapy. Moreover many studies report different although not conflicting results on the miRNAs evaluated for each tumor type. Without doubt, the clinical potential of such molecules for radiotherapy is striking and of high interest.

Indexed as

AnimalsDNA DamageDNA RepairHumansMicroRNAsNeoplasmsRadiation InjuriesRadiation ToleranceSignal TransductionMicroRNAs

Identifiers

PMID24879584
PMCPMC6271831
OpenAlexW2081735304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.